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Inhibitor-Induced Conformational Changes in ASIC1A
Camilla Lund, Christian B. Borg, Timothy Lynagh, Stephan A. Pless.
Department of Drug Design and Pharmacology, University of Copenhagen,
København Ø, Denmark.
Acid-sensing ion channels (ASICs) are involved in acid-induced neuronal
injury during pathological conditions in the central nervous system, such as sei-
zures and ischemic brain injury. These cation-permeable membrane proteins
are also involved in several pain-related mechanisms in the periphery.
Understanding their function and pharmacology is therefore of great interest.
ASICs are activated by protons and inhibited by both small molecule com-
pounds, such as ibuprofen, and peptides like the tarantula toxin psalmotoxin
1 (PcTx1). In this project, Voltage-Clamp Fluorometry (VCF) is used to track
the conformational changes of mASIC1a in response to exposure to both
ibuprofen and PcTx1. We show that ibuprofen induces global, concentration-
dependent conformational changes in the extracellular domain of ASIC1a.
These ibuprofen-induced conformational changes appear to be distinct from
those induced by channel opening and/or desensitization and are therefore
likely to be compound-specific conformational changes. Furthermore, mutation
of a residue critical to functional ibuprofen inhibition, K422, rendered the chan-
nel less sensitive to ibuprofen, but did not affect the concentration-dependence
of the ibuprofen-induced conformational changes. These observations might
help decipher the recently proposed allosteric inhibition mechanism of
ibuprofen. The peptide toxin PcTx1 inhibits ASICs by inducing steady-state
desensitization in ASIC1a. Here we show that it induces global conformational
changes in the extracellular domain that are modulated by the proton concen-
tration in the extracellular solution. Mutations of F350 have previously been
shown to abolish PcTx1 inhibition, but our VCF work shows that the PcTx1-
induced conformational changes persist despite severely reduced PcTx1 inhibi-
tion of the mutant channel. Similar to our observations with ibuprofen, this
strongly suggests that Pctx1 still binds to and interacts with ASIC1a, despite
the mutation-induced reduction of channel inhibition. Together, these findings
provide new insight on inhibitor-induced conformational changes in ASIC1a.
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Evolution of Acid-Sensing Ion Channels
Timothy Lynagh, Janne M. Colding, Stephan A. Pless.
University of Copenhagen, Copenhagen, Denmark.
Each major lineage in the animal kingdom possesses genes from the ENaC/
DEG channel family, a broad family of functionally diverse ion channels. A
small sub-family is that of the acid-sensing ion channels (ASICs), proton-
gated sodium channels that contribute to the neuronal signals underlying, for
example, learning and nociception in mammals. Although ASICs have only
been described in vertebrates, it seems peculiar that such a signaling protein
should be absent from lower organisms that also express such fundamental
behavioral phenotypes. The identification of primitive ASICs has perhaps
been hampered by our poor understanding of the molecular mechanism of
proton-sensing. Here, we use molecular phylogenetics, conventional mutagen-
esis, unnatural amino acid incorporation and electrophysiological recordings to
explore proton-sensing in a broader sample of ASICs than previously possible,
in light of recent genomic data. We find that ASICs are not confined to the
vertebrate lineage, and a comparison of this extended ASIC family with other
ENaC/DEG channels points towards somewhat surprising determinants of
proton-sensing. Using unnatural amino acids, we were able to dissect some
of the chemical interactions behind the molecular mechanism of proton-
sensing. Finally, we provide an explanation for the loss of proton sensitivity
in ASIC4 of the mammalian lineage. Together, this combined evolutionary
and biochemical approach throws new light on the mechanism of proton-
sensing and the distribution of ASICs within the ENaC/DEG family.
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Peptide Modulation of Acid-Sensing Ion Channels
Christian B. Borg, Linda M. Haugaard-Kedstro¨m, Timothy Lynagh,
Kristian Strømgaard, Stephan A. Pless.
Department of Drug Design and Pharmacology, University of Copenhagen,
Copenhagen, Denmark.
Acid-sensing ion channels (ASICs) are homo- or heterotrimeric proton-gated
cation channels which are involved in numerous biological processes, including
initiationof pain andneuronal death associatedwith ischemic stroke.Anumber of
neuropeptides and peptide toxins have been shown capable of modulating ASIC
function and activity. Thus, these peptides have great potential as therapeutics for
the treatment of these disorders, as well as molecular tools for the understanding
and control ofASIC function.Despite the recent advances in structure determina-
tion of ASIC-peptide complexes, the precise molecular mechanisms underlying
peptide modulation of ASICs remain elusive, which hampers the developmentof new and improved ASIC-modulating compounds. In this study, we aimed to
decipher the molecular basis of peptide modulation of ASICs by employing a
combination of molecular biology, electrophysiology, and synthetic peptide
chemistry. Synthetic peptides and peptide analogs were produced by solid-
phase peptide synthesis and their effects on ASICs were measured by two-
electrode voltage clamp electrophysiology. In addition, a series of ASIC conca-
temers were constructed to allow for the introduction of mutation(s) into one or
more specific ASIC subunits. By evaluating the effects of modified ASIC-
modulating peptides on both wild-type, mutated and concatenated ASICs, we
have gained detailed insights into the molecular requirements for peptide modu-
lationofASIC function. Information gained from this studywill allow the rational
design of novel peptides with improved potency and selectivity in the future.
Posters: Ion Channel Regulatory Mechanisms I
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Intragenic Rescue of the Function of Long QT Syndrome-Causing hERG
Mutant Channels
Jordan H. Davis, Jun Guo, Shetuan Zhang.
Biomedical and Molecular Sciences, Queen’s University, Kingston, ON,
Canada.
The human-ether-a-go-go-related gene (hERG) encodes the pore forming sub-
unit of the rapidly activating delayed rectifier Kþ current (IKr) which is impor-
tant for the repolarization phase of cardiac action potentials. A reduction in IKr
due to a loss of hERG function can lead to long QT syndrome (LQTS). There
are a variety of loss-of-function hERG mutations known to cause LQTS, the
majority of which are thought to be trafficking deficient, including G601S. It
has been shown that the plasma membrane (PM) expression of the G601S
hERG mutant can be rescued by reduced temperature culture. We have shown
that wild-type (WT) hERG channels require extracellular Kþ for their stability
in the PM. They undergo internalization under 0 mM Kþ culture conditions,
which can be prevented by reduced temperature culture. We also identified
that the S624T mutation makes hERG insensitive to extracellular Kþ, thereby
preventing hERG channel internalization under 0 mM Kþ culture conditions.
We hypothesize that certain hERG mutants, including G601S, may not be
able to sense extracellular Kþ, making them unstable in the PM, leading to a
loss of PM expression. In this study, we added a secondary mutation, S624T,
which does not depend on extracellular Kþ for its PM expression, to the
G601S mutant hERG channel. The addition of S624T suppressed the loss-of-
function G601S phenotype, and rescued its current to a level similar to WT
channels. The addition of S624T also rescued LQTS-causing hERG mutants
T474I and P596R. Our data reveals the most effective intragenic rescue of
LQTS-causing hERG mutants to date and lends insight into the mechanisms
through which these mutations confer the loss-of-function phenotype.
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Regulation of hERG C-terminal Isoform Expression by KCNH2 Intronic
Elements
Matthew R. Stump1, Sequoyah N. Tate1, Rachel T. Nguyen1,
Anastasiya V. Goldys-Olson2, Qiuming Gong2, Zhengfeng Zhou2.
1Department of Biology, George Fox University, Newberg, OR, USA,
2Knight Cardiovascular Institute, Oregon Health & Science University,
Portland, OR, USA.
TheKCNH2 gene encodes the hERG potassium channel that conducts the rapidly
activating delayed rectifier current in the heart. Two C-terminal hERG isoforms
are expressed in the heart. Splicing ofKCNH2 intron 9 leads to the formation of a
full-length, functional hERGa isoform and polyadenylation of intron 9 results in
the production of a non-functional, C-terminally truncated hERGa-USO isoform.
In the heart, only one-third of KCNH2 pre-mRNA is processed to hERGa due to
inefficient intron9 splicing.Aunique feature ofKCNH2 intron 9 is thepresence of
a 25 nt adenosine stretch immediately downstream of the weak, noncanonical,
polyadenylation site, AGTAAA. Interestingly, non-human primate species
contain the AGTAAA poly(A) site, but differ in the length of the downstream
poly(A) stretch. It is not known how the length of the adenosine stretch effects
the alternative processing ofKCNH2 and the generation of C-terminal hERG iso-
forms. To test the effect of adenosine stretch length on alternative processing, the
KCNH2 intron 9 poly(A) stretch was changed from 25 nt to 13 nt and 33 nt, cor-
responding to the sequences of the marmoset and baboon. In the presence of a 13
nt adenosine stretch, intron 9 splicing outcompeted polyadenylation and resulted
in two-thirds of KCNH2 pre-mRNA being processed to hERGa. Introducing the
33 nt adenosine stretch into intron 9 also resulted in increased hERGa expression
and concomitantly decreased expression of the hERGa-USO isoform.Whole-cell
patch clamp analyses showed increased hERG current in HEK-293 cells trans-
fected with full-length KCNH2 gene constructs containing 13 nt and 33 nt aden-
osine stretches. Although the expression of hERGa-USO has not been previously
